[Heart transplant in "Nuevo Leon": the first 33 cases].
Heart failure is one of the most important causes of death worldwide. Heart transplant is the last effective alternative when the medical and surgical treatments have failed in patients with end stage heart failure, giving them an 80% one year survival rate. Unfortunately, during the outcome, the heart transplant patients can develop complications such as graft rejection and opportunistic infections because of the use of immunosuppressive therapy. In the present article we report the experience with 33 heart transplant patients. Our program not only has successfully transplanted patients with advanced age but, for the first time in Latin America we have transplanted patients assisted with the ambulatory Thoratec TLC II system. Even with limited resources, we have managed the same complications than other heart transplant programs, our 82% one year survival rate is similar than reports in medical literature.
Herrera Garza
Eduardo
E
IMSS Monterrey, Hospital San José TEC de Monterrey. eduardoherrera@intercable.net
Molina Gamboa
Julio
J
Decanini Arcaute
Horacio
H
Ibarra Flores
Marcos
M
Torres García
Myrella
M
Macías Hidalgo
Carlos
C
González Oviedo
Roberto
R
de la Fuente Magallanes
Felipe de Jesús
Fde J
Elizondo Sifuentes
Lius Angel
LA
Villarreal Arredondo
Miguel Angel
MA
Ortega Durán
Oscar
O
Martínez Bermúdez
Pedro
P
García Castillo
Armando
A
Becerra García
Oralia
O
Martínez Rodríguez
Diana
D
Contreras Lara
Carmen
C
Olivares de la Cerda
María de Consuelo
Mde C
Treviño Treviño
Alfonso
A
D000328:Adult; D000368:Aged; D005260:Female; D016027:Heart Transplantation / Q000009:adverse effects / Q000706:statistics & numerical data*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008800:Mexico; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology
D007166:Immunosuppressive Agents